Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Adjunctive GnRH-a treatment attenuates depletion of ovarian reserve associated with cyclophosphamide therapy in premenopausal SLE patients.

Marder W, McCune WJ, Wang L, Wing JJ, Fisseha S, McConnell DS, Christman GM, Somers EC.

Gynecol Endocrinol. 2012 Aug;28(8):624-7. doi: 10.3109/09513590.2011.650752. Epub 2012 Feb 2.

2.

Anti-müllerian hormone and ovarian reserve in systemic lupus erythematosus.

Mok CC, Chan PT, To CH.

Arthritis Rheum. 2013 Jan;65(1):206-10. doi: 10.1002/art.37719.

3.
4.

Brief Report: The Euro-Lupus Low-Dose Intravenous Cyclophosphamide Regimen Does Not Impact the Ovarian Reserve, as Measured by Serum Levels of Anti-Müllerian Hormone.

Tamirou F, Husson SN, Gruson D, Debiève F, Lauwerys BR, Houssiau FA.

Arthritis Rheumatol. 2017 Jun;69(6):1267-1271. doi: 10.1002/art.40079. Epub 2017 May 3.

PMID:
28235250
5.

Gonadotrophin-releasing hormone agonists for fertility preservation: unraveling the enigma?

Hasky N, Uri-Belapolsky S, Goldberg K, Miller I, Grossman H, Stemmer SM, Ben-Aharon I, Shalgi R.

Hum Reprod. 2015 May;30(5):1089-101. doi: 10.1093/humrep/dev037. Epub 2015 Mar 21.

PMID:
25796551
6.

Ovarian reserve diminished by oral cyclophosphamide therapy for granulomatosis with polyangiitis (Wegener's).

Clowse ME, Copland SC, Hsieh TC, Chow SC, Hoffman GS, Merkel PA, Spiera RF, Davis JC Jr, McCune WJ, Ytterberg SR, St Clair EW, Allen NB, Specks U, Stone JH; WGET Research Group.

Arthritis Care Res (Hoboken). 2011 Dec;63(12):1777-81. doi: 10.1002/acr.20605.

7.

The impact of cyclophosphamide on menstruation and pregnancy in women with rheumatologic disease.

Harward LE, Mitchell K, Pieper C, Copland S, Criscione-Schreiber LG, Clowse ME.

Lupus. 2013 Jan;22(1):81-6. doi: 10.1177/0961203312468624.

PMID:
23263867
8.

[Protective effect of GnRH analogues on the reproductive capacity of women with neoplasia or autoimmune disease who require chemotherapy. Final results of a phase ii clinical trial].

Gris-Martínez JM, Trillo-Urrutia L, Gómez-Cabeza JJ, Encabo-Duró G.

Med Clin (Barc). 2016 Feb 5;146(3):97-103. doi: 10.1016/j.medcli.2015.04.032. Epub 2015 Jul 17. Spanish.

PMID:
26194532
9.

The impact of depot GnRH agonist on AMH levels in healthy reproductive-aged women.

Su HI, Maas K, Sluss PM, Chang RJ, Hall JE, Joffe H.

J Clin Endocrinol Metab. 2013 Dec;98(12):E1961-6. doi: 10.1210/jc.2013-2410. Epub 2013 Sep 30.

10.

[Assessment of ovarian reserve with anti-Müllerian hormone in female patients with systemic lupus erythematosus].

Chen D, Yuan S, Zhan Z, Zhan Y, Yang X, Liang L.

Zhonghua Yi Xue Za Zhi. 2014 Apr 8;94(13):977-80. Chinese.

PMID:
24851682
11.

Impact of systemic lupus erythematosus on ovarian reserve in premenopausal women: evaluation by using anti-Muellerian hormone.

Lawrenz B, Henes J, Henes M, Neunhoeffer E, Schmalzing M, Fehm T, Kïtter I.

Lupus. 2011 Oct;20(11):1193-7. doi: 10.1177/0961203311409272. Epub 2011 Jul 18.

PMID:
21768179
12.

Study of anti-Müllerian hormone and its relation to the subsequent probability of pregnancy in 112 patients with systemic lupus erythematosus, exposed or not to cyclophosphamide.

Morel N, Bachelot A, Chakhtoura Z, Ghillani-Dalbin P, Amoura Z, Galicier L, Aumaitre O, Piette JC, Pourrat J, Boutin D, Sacre K, Kahn JE, Duhaut P, Farge D, Francès C, Guettrot-Imbert G, Harlé JR, Lambotte O, Le Guern V, Sène D, Trad S, Vidal E, Sarrot-Reynauld F, Gompel A, Tanguy ML, Touraine P, Lacorte JM, Costedoat-Chalumeau N; PLUS group.

J Clin Endocrinol Metab. 2013 Sep;98(9):3785-92. doi: 10.1210/jc.2013-1235. Epub 2013 Jul 5.

PMID:
23833039
13.

Serum Anti-Müllerian Hormone Levels in Precocious Puberty Girls according to Stage of GnRH Agonist Treatment.

Nam HK, Kim HR, Rhie YJ, Lee KH.

J Korean Med Sci. 2017 Mar;32(3):475-479. doi: 10.3346/jkms.2017.32.3.475.

14.
15.

Assessment of anti-Müllerian hormone levels in premenopausal patients with systemic lupus erythematosus.

Gasparin AA, Souza L, Siebert M, Xavier RM, Chakr RM, Palominos PE, Brenol JC, Monticielo OA.

Lupus. 2016 Mar;25(3):227-32. doi: 10.1177/0961203315598246. Epub 2015 Jul 28.

PMID:
26223296
16.

Serum levels of antimüllerian hormone in early maturing girls before, during, and after suppression with GnRH agonist.

Hagen CP, Sørensen K, Anderson RA, Juul A.

Fertil Steril. 2012 Nov;98(5):1326-30. doi: 10.1016/j.fertnstert.2012.07.1118. Epub 2012 Aug 14.

PMID:
22901847
17.
18.

GnRH agonist leuprolide acetate does not confer any protection against ovarian damage induced by chemotherapy and radiation in vitro.

Bildik G, Akin N, Senbabaoglu F, Sahin GN, Karahuseyinoglu S, Ince U, Taskiran C, Selek U, Yakin K, Guzel Y, Ayhan C, Alper E, Cetiner M, Balaban B, Mandel NM, Esen T, Iwase A, Urman B, Oktem O.

Hum Reprod. 2015 Dec;30(12):2912-25. doi: 10.1093/humrep/dev257. Epub 2015 Oct 13.

PMID:
26466909
19.

Anti-Müllerian hormone in reproductive age women with systemic lupus erythematosus.

Velarde-Ochoa Mdel C, Esquivel-Valerio JA, Vega-Morales D, Skinner-Taylor CM, Galarza-Delgado DÁ, Garza-Elizondo MA.

Reumatol Clin. 2015 Mar-Apr;11(2):78-82. doi: 10.1016/j.reuma.2014.03.009. Epub 2014 May 10. English, Spanish.

20.

Supplemental Content

Support Center